ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne

Figures & data

Table 1. Clinical and demographic data according to the treatment subgroups.

	TREATMENT
	COC(n = 20)	AA(n = 18)	p-valor
Age^a (years)	33,7 ± 5,5	33,1 ± 5,3	0,695^#
Smoking	1 (5,0%)	2 (11,8%)	0,584^##
“U type” lesion distribution	14 (70,0%)	13 (72,2%)	>0,999^##
Onset of acne			0,516^&
adolescence	9 (45,0%)	10 (55,6%)
adult	11 (55,0%)	8 (44,4%)
Intensity			0,132^###
none	—	—
comedones and rare papules	1 (5,0%)	1 (5,6%)
predominance of papules and pustules	18 (90,0%)	12 (66,7)
nodules	1 (5,0%)	5 (27,8%)

^a amean ± standanrd deviation.

^# Student T test /.

^## Fisher's exact test /.

^### generalization of Fishers's exact test.

^& chi-square.

Figure 1. Error bar graphs representing mean ± standard deviation values obtained in ADT-G levels in acne and control groups, before treatment.

Figure 2. Profile chart of subgroups, ADT-G levels before and after treatments.

Figure 3. Profile graph of subgroups, free testosterone (FT) levels before and after treatments.

Figure 4. Correlation between FT and ADT-G, before treatment – Spearman Correlation Coefficient: r = 0.43 – 95% CI [0.143; 0.668].